Plantibodies is a unique plant based platform to mass produce antibodies for immunotherapy. We intend on developing the next generation of medical treatment to cure life threatening and terminal diseases.
Antibodies produced on our platform are intended for human consumption in immunotherapy against cancers, neurodegenerative diseases, and autoimmune diseases.
The number of patients who suffer from life threatening and incurable diseases such as cancer, neurodegenerative diseases, and pathogenic infections is rising steadily. For example, in the USA over 1.7 million people diagnosed with cancer each year, costing over $147 billion dollars (2017), and 5.4 million people are diagnosed with Alzhimers and Parkinsons globally (2016). These patients have no efficient treatment for these diseases. Or the treatments are expensive, unsafe (chemotherapy), and have excessive side effects.
Our aim is to help these patients manage their disease by boosting their own lymphocytes. We would reduce painful side effects, while removing the disease from their bodies.
We intend to develop antibodies against these terminal diseases to stimulate the patient's own immune system. The stimulated immune system would attack the diseased cells and phagocytes them from the body. A naturally occurring process enhanced by our antibodies.
Our vision is to produce safer, efficient, and cheaper antibodies for human consumption. We believe that the next generation of medicine should be efficient, affordable, and minimal side effects.